LyondellBasell (LYB) Form 144: 20,000 RSU shares for sale (~$1.07M)
Rhea-AI Filing Summary
LyondellBasell (LYB) insider plans to sell 20,000 shares through J.P. Morgan Securities on or about 08/15/2025, with an aggregate market value of $1,066,200 based on the filing. The shares were acquired through RSU vesting: 12,906 shares vested on 05/23/2023 and 7,094 shares vested on 02/22/2025; payment for those RSUs was recorded as compensation. The filing reports no other sales by the person in the past three months. The notice includes the standard representation that the seller is not aware of any undisclosed material adverse information about the issuer.
Positive
- Sale is small relative to outstanding shares (~0.0062%), limiting potential market impact
- All shares were acquired via RSU vesting and paid as compensation, indicating this is a liquidity action for vested compensation
- Execution through a major broker (J.P. Morgan Securities LLC) provides an orderly market channel for the sale
Negative
- None.
Insights
TL;DR: Routine insider sale of vested RSUs totaling 20,000 shares (~$1.07M) executed through a major broker; small relative to outstanding shares.
The filing documents a proposed sale of 20,000 common shares via J.P. Morgan Securities with an aggregate market value of $1,066,200. All shares were acquired through RSU vesting events and paid as compensation, indicating this is a liquidity action for compensation-related shares rather than a market purchase or financing. The sale size represents approximately 0.0062% of the issuer's reported outstanding shares (20,000 of 321,648,429), so the direct market impact is likely negligible. The filer reports no sales in the prior three months and provides the standard attestation regarding material undisclosed information.
TL;DR: Disclosure is a standard Form 144 insider notice tied to vested RSUs; documentation and broker route are routine and compliant in form.
The notice lists the acquisition dates and nature (RSU vesting) for all shares to be sold and identifies the executing broker (J.P. Morgan Securities LLC). The form includes the seller's attestation that no undisclosed material adverse information is known, which is customary. There are no reported sales in the prior three months, and the payment/source for the securities is recorded as compensation. From a governance perspective, this filing appears to be a routine compliance disclosure rather than a corporate governance event.
FAQ
What does the LYB Form 144 report?
How were the LYB shares being sold acquired?
Has the filer sold LYB shares in the past three months?
What fraction of LYB's outstanding shares does this sale represent?
Does the filing indicate any undisclosed material information about LYB?